CCL11 and asthma: These findings along with information that overexpression of miR-221-3p intensifies airway eosinophilic inflammation and enhances expression of both eotaxins may lead to conclusion that epithelial and sputum miR-221-3p may be a novel biomarker for airway eosinophilic inflammation in asthma [68].